In the Weeds: A Comprehensive Review of Cannabis; Its Chemical Complexity, Biosynthesis, and Healing Abilities

Overview

Journal Toxicol Rep

Date 2024 Jul 26

PMID 39056093

Authors

Fatima-Zahrae Laaboudi

Mohamed Rejdali

Hassan Amhamdi

Amin Salhi

Abedellah Elyoussfi

M hamed Ahari

Affiliations

Soon will be listed here.

Abstract

For millennia, various cultures have utilized cannabis for food, textile fiber, ethno-medicines, and pharmacotherapy, owing to its medicinal potential and psychotropic effects. An in-depth exploration of its historical, chemical, and therapeutic dimensions provides context for its contemporary understanding. The criminalization of cannabis in many countries was influenced by the presence of psychoactive cannabinoids; however, scientific advances and growing public awareness have renewed interest in cannabis-related products, especially for medical use. Described as a 'treasure trove,' cannabis produces a diverse array of cannabinoids and non-cannabinoid compounds. Recent research focuses on cannabinoids for treating conditions such as anxiety, depression, chronic pain, Alzheimer's, Parkinson's, and epilepsy. Additionally, secondary metabolites like phenolic compounds, terpenes, and terpenoids are increasingly recognized for their therapeutic effects and their synergistic role with cannabinoids. These compounds show potential in treating neuro and non-neuro disorders, and studies suggest their promise as antitumoral agents. This comprehensive review integrates historical, chemical, and therapeutic perspectives on cannabis, highlighting contemporary research and its vast potential in medicine.

Citing Articles

Cannabis: Zone Aspects of Raw Plant Components in Sport-A Narrative Review.

Flangea C, Vlad D, Popescu R, Dumitrascu V, Rata A, Tryfon M Nutrients. 2025; 17(5).

PMID: 40077729 PMC: 11902196. DOI: 10.3390/nu17050861.

Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review.

Doumar H, Mostafi H, Elhessni A, Touhami M, Mesfioui A IBRO Neurosci Rep. 2025; 18:96-119.

PMID: 39866750 PMC: 11763173. DOI: 10.1016/j.ibneur.2024.12.011.

Edible cannabis for chronic low back pain: associations with pain, mood, and intoxication.

Melendez S, Ortiz Torres M, Lisano J, Giordano G, Skrzynski C, Hutchison K Front Pharmacol. 2024; 15:1464005.

PMID: 39380911 PMC: 11458467. DOI: 10.3389/fphar.2024.1464005.

References

Blebea N, Hancu G, Vlad R, Pricopie A . Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices. Molecules. 2023; 28(2). PMC: 9862621. DOI: 10.3390/molecules28020638. View

BARRETT M, Scutt A, Evans F . Cannflavin A and B, prenylated flavones from Cannabis sativa L. Experientia. 1986; 42(4):452-3. DOI: 10.1007/BF02118655. View

Preet A, Ganju R, Groopman J . Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene. 2007; 27(3):339-46. DOI: 10.1038/sj.onc.1210641. View

Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I . Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 2011; 18(7):1099-111. PMC: 3131949. DOI: 10.1038/cdd.2011.32. View

Lewis M, Yang Y, Wasilewski E, Clarke H, Kotra L . Chemical Profiling of Medical Cannabis Extracts. ACS Omega. 2018; 2(9):6091-6103. PMC: 6044620. DOI: 10.1021/acsomega.7b00996. View

Maurya N, Velmurugan B . Therapeutic applications of cannabinoids. Chem Biol Interact. 2018; 293:77-88. DOI: 10.1016/j.cbi.2018.07.018. View

Salazar M, Carracedo A, Salanueva I, Hernandez-Tiedra S, Egia A, Lorente M . TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action. Autophagy. 2009; 5(7):1048-9. DOI: 10.4161/auto.5.7.9508. View

Zheljazkov V, Maggi F . Valorization of CBD-hemp through distillation to provide essential oil and improved cannabinoids profile. Sci Rep. 2021; 11(1):19890. PMC: 8494916. DOI: 10.1038/s41598-021-99335-4. View

Szaflarski J, Bebin E, Cutter G, DeWolfe J, Dure L, Gaston T . Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy Behav. 2018; 87:131-136. DOI: 10.1016/j.yebeh.2018.07.020. View

10.

Rupasinghe H, Davis A, Kumar S, Murray B, Zheljazkov V . Industrial Hemp ( subsp. ) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. Molecules. 2020; 25(18). PMC: 7571072. DOI: 10.3390/molecules25184078. View

11.

Koltai H, Namdar D . Cannabis Phytomolecule 'Entourage': From Domestication to Medical Use. Trends Plant Sci. 2020; 25(10):976-984. DOI: 10.1016/j.tplants.2020.04.007. View

12.

Radwan M, Chandra S, Gul S, ElSohly M . Cannabinoids, Phenolics, Terpenes and Alkaloids of . Molecules. 2021; 26(9). PMC: 8125862. DOI: 10.3390/molecules26092774. View

13.

Baek S, Kim Y, Kwag J, Choi K, Jung W, Han D . Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells. Arch Pharm Res. 1999; 21(3):353-6. DOI: 10.1007/BF02975301. View

14.

Zhu L, Sharma S, Stolina M, Gardner B, Roth M, Tashkin D . Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000; 165(1):373-80. DOI: 10.4049/jimmunol.165.1.373. View

15.

Xu D, Cullen B, Tang M, Fang Y . The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. Curr Pharm Biotechnol. 2019; 21(5):390-402. DOI: 10.2174/1389201020666191202111534. View

16.

Hanus L, Meyer S, Munoz E, Taglialatela-Scafati O, Appendino G . Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016; 33(12):1357-1392. DOI: 10.1039/c6np00074f. View

17.

Montero L, Ballesteros-Vivas D, Gonzalez-Barrios A, Sanchez-Camargo A . Hemp seeds: Nutritional value, associated bioactivities and the potential food applications in the Colombian context. Front Nutr. 2023; 9:1039180. PMC: 9875026. DOI: 10.3389/fnut.2022.1039180. View

18.

Izzo A, Borrelli F, Capasso R, Di Marzo V, Mechoulam R . Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009; 30(10):515-27. DOI: 10.1016/j.tips.2009.07.006. View

19.

Di Marzo V, Bifulco M, De Petrocellis L . The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004; 3(9):771-84. DOI: 10.1038/nrd1495. View

20.

Pegoraro C, Nutter D, Thevenon M, Ramirez C . Chemical profiles of cannabis sativa medicinal oil using different extraction and concentration methods. Nat Prod Res. 2019; 35(13):2249-2252. DOI: 10.1080/14786419.2019.1663515. View